188 related articles for article (PubMed ID: 29213987)
21. HIV-Associated Dementia: Associated Factors and Characteristics of Cognitive Domain Abnormalities in Elderly People Living with HIV Treated with Highly Active Antiretroviral Therapy.
Boonyagars L; Kiatsoongsong N; Winitprichagul S
Am J Trop Med Hyg; 2022 Dec; 107(6):1250-1257. PubMed ID: 36315995
[TBL] [Abstract][Full Text] [Related]
22. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
23. HIV, antiretroviral therapies, and the brain.
Liner KJ; Ro MJ; Robertson KR
Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
[TBL] [Abstract][Full Text] [Related]
24. Role of neuroimaging in HIV-associated neurocognitive disorders.
Masters MC; Ances BM
Semin Neurol; 2014 Feb; 34(1):89-102. PubMed ID: 24715492
[TBL] [Abstract][Full Text] [Related]
25. Evolving clinical phenotypes in HIV-associated neurocognitive disorders.
Sacktor N; Robertson K
Curr Opin HIV AIDS; 2014 Nov; 9(6):517-20. PubMed ID: 25203640
[TBL] [Abstract][Full Text] [Related]
26. HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria.
Chan LG; Kandiah N; Chua A
BMJ Open; 2012; 2(1):e000662. PubMed ID: 22331389
[TBL] [Abstract][Full Text] [Related]
27. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia.
Foley JM; Wright MJ; Gooding AL; Ettenhofer M; Kim M; Choi M; Castellon SA; Sadek J; Heaton RK; van Gorp WG; Marcotte TD; Hinkin CH
Int Psychogeriatr; 2011 Jun; 23(5):835-43. PubMed ID: 21092351
[TBL] [Abstract][Full Text] [Related]
28. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
[TBL] [Abstract][Full Text] [Related]
29. Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders.
Silva K; Hope-Lucas C; White T; Hairston TK; Rameau T; Brown A
J Neurovirol; 2015 Apr; 21(2):174-85. PubMed ID: 25636782
[TBL] [Abstract][Full Text] [Related]
30. HIV, aging, and cognition: emerging issues.
Valcour VG
Top Antivir Med; 2013; 21(3):119-23. PubMed ID: 23981600
[TBL] [Abstract][Full Text] [Related]
31. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
Rourke SB; Bekele T; Rachlis A; Kovacs C; Brunetta J; Gill MJ; Carvalhal A; Cysique LA; Marcotte T; Power C
AIDS; 2021 Jan; 35(1):63-72. PubMed ID: 33048883
[TBL] [Abstract][Full Text] [Related]
32. Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
Force G; Ghout I; Ropers J; Carcelain G; Marigot-Outtandy D; Hahn V; Darchy N; Defferriere H; Bouaziz-Amar E; Carlier R; Dorgham K; Callebert J; Peytavin G; Delaugerre C; de Truchis P;
J Antimicrob Chemother; 2021 Feb; 76(3):743-752. PubMed ID: 33179033
[TBL] [Abstract][Full Text] [Related]
33. Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China.
Zhao T; Wei B; Long J; Tang X; Zhou M; Dang C
J Neurovirol; 2015 Feb; 21(1):32-42. PubMed ID: 25361696
[TBL] [Abstract][Full Text] [Related]
34. Untangling the Gordian knot of HIV, stress, and cognitive impairment.
Valdez AN; Rubin LH; Neigh GN
Neurobiol Stress; 2016 Oct; 4():44-54. PubMed ID: 27981189
[TBL] [Abstract][Full Text] [Related]
35. Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria.
Jumare J; Akolo C; Ndembi N; Bwala S; Alabi P; Okwuasaba K; Adebiyi R; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
J Acquir Immune Defic Syndr; 2020 Jun; 84(2):196-202. PubMed ID: 32084055
[TBL] [Abstract][Full Text] [Related]
36. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
37. The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders.
Moore DJ; Sun-Suslow N; Nichol AA; Paolillo EW; Saloner R; Letendre SL; Iudicello J; Morgan EE
AIDS; 2024 Apr; 38(5):645-655. PubMed ID: 38051787
[TBL] [Abstract][Full Text] [Related]
38. Profile of HIV/AIDS Neurocognitive Impairment among HIV Positive Patients in North Central Nigeria.
Osaigbovo OG; Ugoya S; Ogunniyi A
West Afr J Med; 2015; 34(3):179-184. PubMed ID: 28276043
[TBL] [Abstract][Full Text] [Related]
39. Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV.
Zamudio-Rodríguez A; Belaunzarán-Zamudio PF; Sierra-Madero JG; Cuellar-Rodríguez J; Crabtree-Ramírez BE; Alcala-Zermeno JL; Amieva H; Avila-Funes JA
AIDS Res Hum Retroviruses; 2018 May; 34(5):449-455. PubMed ID: 29385834
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
